A Study of Denosumab in Multiple Myeloma Patients With Renal Insufficiency
NCT02833610
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
55
Enrollment
OTHER
Sponsor class
Conditions
Multiple Myeloma
Interventions
DRUG:
Denosumab Q4W
Sponsor
Massachusetts General Hospital
Collaborators
[object Object]
[object Object]
[object Object]
[object Object]